← SynDRA
TASQUINIMOD
SynDRA canonical compound SYN0033237 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | HDAC4 |
|---|
| Mechanism of action | Angiogenesis inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- S100A9 INHIBITOR
- angiogenesis inhibitor
- HDAC4 INHIBITOR
- S100A9 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- TASQ
- ABR-215050
- tasquinimodum
- RefChem:891191
- DTXCID00102674
- Tasquinimod [INN]
- MFCD18251454
- UNII-756U07KN1R
- TASQUINIMOD [MI]
- TASQUINIMOD [WHO-DD]
- GTPL8098
- orb1300548
- orb3141139
- SCHEMBL4476895
- Tasquinimod(ABR-215050)?
- SCHEMBL29362522
- CHEBI:231355
- GLXC-90157
- ABR215050
- BDBM50565139
- s7617
- AKOS027250776
- CCG-268712
- CS-0898
- SB16938
- NCGC00379032-02
- NCGC00379032-04
- AC-32481
- AS-35208
- HY-10528
- DS-001403
- NS00068362
- T6695
- F799832
- BRD-K14653796-001-01-1
Look up TASQUINIMOD in the interactive SynDRA portal →